The adsorptive properties of eight forms of nano-TiO 2 were evaluated when they were exposed to the toxic thiol-containing amino acid homocysteine. Homocysteine is an amino acid known to cause cardiovascular toxicity and neurodegenerative disorders. A homocysteine standard solution was combined with dispersions of each TiO 2 nanoparticle under physiological conditions, and then a high-performance liquid chromatography fluorescence detection method optimized for quantification of total, unbound homocysteine was utilized. The nano-sized anatase nanoparticle removed 2.92 mg of homocysteine per microgram of nanoparticle, whereas amorphous TiO 2 only removed 3.65 ¥ 10 -3 mg of homocysteine per microgram of nanoparticle. Other nanoparticles produced values between the anatase and amorphous forms. Surface chemistries are distinguishing characteristics of these nanoparticles and are responsible for their individual physicochemical properties. Variations in results were associated with the unique combinations of size and surface area of each nanoparticle. The aminothiol adsorptive property of TiO 2 nanoparticles has potential applications in nanomedicine, biosensing, diagnostics and amino acid tagging.
INTRODUCTION
The present study examined the adsorption characteristics of eight forms of titanium(IV) oxide (titanium dioxide, TiO 2 ) nanoparticles (1 micro-sized and 7 nano-sized particles) with the thiolcontaining amino acid, homocysteine, a precursor of the amino acid methionine. The biosynthesis of methionine from homocysteine requires both folate and vitamin B 12 (Figure 1 ). Therefore, diets deficient in folate and/or vitamin B 12 result in measurably elevated total plasma homocysteine levels, which is a known risk factor for cardiovascular disease and neural tube defects in utero (Rogers et al. 2007) . Furthermore, the decreased production of methionine results in a reduction in the levels of S-adenosylmethionine, an important methyl group donor .
The adsorptive property of the TiO 2 nanoparticles studied makes them suitable for medical, diagnostic and imaging applications if engineered properly. One potential application of TiO 2 nanoparticles may be nano-bio interactions with aminothiols (e.g. glutathione, cysteine and homocysteine). Homocysteine was chosen in this study due to its biological importance as a naturally produced aminothiol that contributes to multiple pathological conditions in humans.
Elevated levels of total plasma homocysteine have been associated with cardiovascular disease and when combined with low folate levels, they are associated with Alzheimer's disease (Mudd and Levy 1995; Franken et al. 1996; Shea et al. 2002) . Serious neurodegenerative and cardiovascular complications arise when homocysteine level is elevated in the plasma. A correlation exists between high plasma homocysteine levels and risk of stroke (Rogers et al. 2007 ). In addition, elevated homocysteine levels (>15 mmol/l) have been associated with a widespread loss of grey matter and thus, low cognitive scores (Ford et al. 2012 ). There are three major fates of homocysteine. First, folate and vitamin B 12 are required to convert homocysteine to methionine. Second, folate/B 12 deficiency leads to excessive export of homocysteine from the cells towards the bloodstream, resulting in an elevated plasma homocysteine level or hyperhomocysteinemia. Third, homocysteine can be converted to cysteine and glutathione through the trans-sulphuration pathway (Shea et al. 2002; Rogers et al. 2007) .
Interesting potential clinical applications of TiO 2 nanoparticles' aminothiol removal properties could be in treatment of conditions such as familial hyperhomocysteinemia. However, before any in vivo therapeutic interventions with nanoparticles are explored, their effects on renal function and clearance must be studied. The endothelial cells of the glomerular tuft in humans are fenestrated on average between 50 and 100 nm (McBride 1998) . However, it has been reported that nanoparticles ranging in primary particle size between 10 and 250 nm can cause the formation of larger complexes consisting of proteins and nanoparticles, which are too large to be cleared by the renal system (Zhang et al. 2014b) . Zhang et al. (2014b) propose that the combined use of stable ligands and nanoparticles with primary particle sizes less than 5.5 nm is crucial for successful renal clearance. Lee et al. (2013) found that 1.5-nm gold nanoparticles used for X-ray contrast media were cleared by the kidneys in mice, whereas gold nanoparticles coated in polyethylene glycol (approximately 30 nm) were not cleared by the kidneys and were accumulated within the reticuloendothelial tissue. Ma et al. (2012) and Malfatti et al. (2012) have also reported a similar finding. Malfatti et al. monitored the pharmacokinetics of silica 592 A. Stella et al./Adsorption Science & Technology Vol. 32 No. 7 nanoparticles (20-25 nm in diameter) in mice and reported that the majority of silica nanoparticles were eliminated through the urine (69.4%) at a rate of 54.4 ml/hour/kg, whereas 30.6% of elimination took place through the faeces at a rate of 25.8 g/hour/kg.
In vitro diagnostics is another area in which the utilization of TiO 2 nanoparticles could be beneficial (as a nano-biosensor application). One application could be the measurement of homocysteine levels, which involves tagging TiO 2 nanoparticles and then adsorbing homocysteine from samples, providing a faster and a more cost-effective way to perform the analysis. This approach could also be extended to the measurement of other circulating aminothiols such as cysteine and glutathione. Huang and Tseng (2008) reported the use of gold nanoparticles to sense and remove homocysteine thiolactone, which is a cyclic thioester of homocysteine. A study by Zhang et al. (2014a) reported the usefulness of adsorbing DNA oligonucleotides onto TiO 2 nanoparticles. This characteristic of adsorbing biomolecules onto the surface of TiO 2 nanoparticles makes these nanoparticles excellent candidates for nanomedicine applications whether a biomolecule is being delivered to a cell (DNA oligonucleotides) or being removed from the body (homocysteine). In addition, the study by Zhang et al. (2014a) also used fluorescence detection, demonstrating that TiO 2 nanoparticles have qualities suitable for use in laboratory detection methodologies.
TiO 2 nanoparticles are gaining popularity in common consumer products and in medicine, and therefore they were chosen for evaluation in this study. TiO 2 is a transition metal oxide photocatalyst that is transparent to visible light, but absorbs in the ultraviolet (UV) region, making it ideal for use in paints, cosmetics and self-cleaning materials (Auffan et al. 2010) . Their popularity is generally due to their physical and chemical stability, high catalytic activity, high oxidative power, low cost and ease of production (Seery et al. 2007) . TiO 2 nanoparticles are among the most widely studied semiconducting photocatalysts and are widespread in many cosmetic products (Hamilton et al. 2009 ). Use of nano-sized metal oxides in biosensors and in the analytical chemistry field has proven beneficial for medical diagnostics. Zhang et al. (2014a) have already demonstrated the bio-adsorptive qualities of TiO 2 . These bio-adsorptive characteristics of TiO 2 nanoparticles are attractive for a wide array of biological and clinical applications. The present approach of using common TiO 2 nanoparticles provides an array of different adsorption capacities and uses a more cost-effective material.
These developments have allowed for a greater understanding of nanoparticle-biological (nano-bio) interactions that may be advantageous for the design of nanopharmaceuticals (Hahm 2013; Hsieh et al. 2013) . In general, metal oxides are also gaining popularity in other areas of sensor development due to specific optical, electrochemical, electrical, gravimetric, acoustic and magnetic properties related to transduction of signals, and have provided product improvement for sensing electrodes (Hahm 2013; Pandey et al. 2013) .
Currently, nano-sized metal oxides have been used in many diagnostic imaging and pharmacokinetic studies in vivo. Ma et al. (2012) used folic acid-conjugated nanoprobes for targeting dual-modality imaging in mice. In a similar study, Jokerst et al. (2012) used silicacoated gold nanorods for the imaging and quantification of mesenchymal stem cells in rodent muscle. In a pharmacokinetic study, Malfatti et al. (2012) demonstrated that silicon dioxide (SiO 2 ) nanoparticles administered to mice cleared the central compartment, distributed themselves to the reticuloendothelial system tissue, and persisted in these tissues throughout the 8-week study period.
Regardless of whether the setting is in vitro (e.g. environmental, laboratory diagnostics) or in vivo (e.g. nanomedicinal, nanopharmaceutical), the ability of TiO 2 nanoparticles to adsorb or remove biomolecules, which depends on the surface chemistry of the particles, is a key characteristic that has significant potential applications. The present study examined the removal of homocysteine, a common biomolecule, by TiO 2 nanoparticles under physiological conditions in solution. The evaluation of homocysteine removal by common TiO 2 nanoparticles was performed using a high-performance liquid chromatography (HPLC) method with fluorescence detection. The current approach provided characterization of each form of nanoparticle while also providing specific results and may be considered a useful approach for evaluations of nano-bio interactions.
EXPERIMENTAL ANALYSIS 2.1. TiO 2 Materials
A total of eight TiO 2 materials were used to determine homocysteine removal from a physiological solution. The TiO 2 materials evaluated were (i) micro-sized rutile, (ii) nano-sized anatase, (iii) rutile, (iv) P90, (v) P25, (vi) NKT90, (vii) T805 and (viii) amorphous. Table 1 presents additional properties and the source of these materials. Each nanoparticle had a unique combination of specific surface area (SSA), primary particle size and polarity (water solubility). The non-polar nanoparticles were coated by octylsilane (T805) and alkylsilane (NKT90).
Transition Metals
Transition metals in the nanoparticles were determined in the water-soluble extract (at 37 ˚C while mixing for 90 minutes) with a specific and sensitive inductively coupled plasma mass spectrometry (ICP-MS) method (Bello et al. 2009 ). The analyses were conducted on an Agilent 7500 CS system at the University of Washington.
Dispersions of Materials
Dispersions of TiO 2 nanoparticles were prepared by dispersing 10 mg of material into 1 ml of isotonic phosphate-buffered saline (PBS, pH 7.4; 10:1 mass-to-volume ratio). The material dispersion was then combined in a 1:1 volume-to-volume ratio (1:1 ml) with a 10mM homocysteine (Sigma-Aldrich, St. Louis, MO) standard, which upon dilution produced a physiologically normal serum total homocysteine concentration of 5mM. Monodispersity was not evaluated because dispersion in a biological matrix does not guarantee pure monodispersion. Rather, nanoparticles were allowed to disperse freely into the homocysteine standard solution. 
HPLC Fluorescence Detection Conditions
An Agilent (Agilent Technologies, Santa Clara, CA) 1100 series HPLC system equipped with an Agilent fluorescence detector (HPLC-FLD) was used for the analysis, following homocysteine quantification based on the method developed by Araki and Sako (1987) . The mobile phase consisted of 97.32% water with 0.68% sodium acetate (Sigma-Aldrich) and 2.00% methanol (Burdick & Jackson, Muskegon, MI). The flow rate was isocratic, set at 0.5 ml/minute, and the reducing agent tris(2-carboxyethyl)phosphine (TCEP) (Sigma-Aldrich) was used to convert all oxidized (R-S-S-R) forms of homocysteine (symmetric or mixed disulphides, or homocysteine thiolactone) to the reduced (2R-SH) form (Ueland 1995; Ferguson et al. 1998) . The thiol group of homocysteine was derivatized using the ammonium salt of 7-fluorobenzofurazan-4-sulphonic acid (SBD-F) (Sigma-Aldrich), which is specific for thiols, and thus eliminating background interference. A 50-ml aliquot of the reduced and derivatized sample was injected into a Thermo (Waltham, MA) Hypersil ODS column (50 ¥ 4.6 mm) with a particle size of 3 mm. The florescence detector was set at 385 nm for excitation and 515 nm for emission. The total analysis time was 6 minutes (Araki and Sako 1987) .
Quantification of Homocysteine Adsorption/Removal
The material dispersion was combined with the homocysteine standard in a glass reaction vial for 1 hour at 37 ˚C while rotating at 500 rpm (VWR International, Radnor, PA). Upon completion, reaction vials were centrifuged for 8 minutes at 1536 relative centrifugal force (RCF) and then an aliquot was ultracentrifuged two times at 14,000 RCF to remove the TiO 2 nanoparticles (Bello et al. 2009) . A 100-ml aliquot of the ultracentrifuged supernatant was used for HPLC analysis following the method of Araki and Sako for free homocysteine determination (Araki and Sako 1987) . The adsorbed homocysteine was removed from the assay with the TiO 2 nanoparticles by centrifugation. Total homocysteine (in the reduced R-SH form) was then measured by HPLC-FLD.
RESULTS

Transition Metals
The total metal content of the nanoparticles measured by ICP-MS is presented in Table 2 . Most metals in the water extract were near or below the detection limit. 
Free Homocysteine
SBD-F specifically derivatizes homocysteine in its reduced form (R-SH). This is also the free, non-adsorbed and reduced (R-SH) form, and thus chromatograms from the HPLC analysis represent isolated peaks containing free homocysteine. Reduction in peak area was associated with high homocysteine removal (Figure 2) . A decrease in the fluorescent signal specifically indicated a decreased homocysteine concentration, and thus a decreased removal. In the present system, there were no interferences that would have been responsible for decreasing the obtained signal. Using a decreasing signal to evaluate nano-bio interactions is unique in that, in this system, only removal of the adsorbent can cause the decrease in signal. The use of increasing signals to evaluate nano-bio interactions aids in detecting falsely elevated signals from sources such as background noise and catalytic metals originating from the nanoparticles. The results revealed a varying degree of homocysteine adsorption among the various TiO 2 nanoparticles (Figure 2) . Each of the TiO 2 nanoparticles has a unique SSA, primary particle size and polarity (Table 1 ). The variation in the results reflected the differences in surface chemistry and physicochemical properties between nanoparticles which highlighted the diversity of nanoTiO 2 . Nanoparticles containing the greatest amount of anatase, combined with the smallest primary particle size, adsorbed the highest amounts of homocysteine. All values were significantly different from the blank value (p < 0.05). 
Adsorbed Homocysteine per Milligram of Nanoparticle
The mass of aminothiol adsorbed on each nanoparticle was also calculated (Figure 3) . Here, the amount of free (residual) homocysteine (i.e. the amount that was not adsorbed) was directly measured by HPLC. Subtracting the measured value from the 5 mmol of homocysteine in the blank standard sample gave the amount of homocysteine removed from solution. A conversion to microgram of homocysteine/milligram of nanoparticle was performed by converting micromole of residual homocysteine (molar mass = 135.18 g/mol) to microgram of residual homocysteine and then dividing the value by the original mass of nanoparticle present under these conditions (10 mg for the present study):
(1) Nano-anatase adsorbed the highest amount of homocysteine (29.25 mg/mg), whereas the nonpolar NKT90 nanoparticle adsorbed the least (4.555 mg/mg). Figure 4 shows the amount of homocysteine (expressed in micrograms) adsorbed per milligram of nanoparticle. All values were significant (p < 0.05).
Correction for Primary Particle Size
The mass of aminothiol adsorbed per milligram of nanoparticle, corrected for primary particle size, was also calculated and plotted in Figure 5 . The primary particle size is the length, in nanometres, of the smallest dimension of the nanoparticle. The mass removed per milligram of nanoparticle was calculated by dividing the amount of homocysteine removed by the primary particle size of each unique nanoparticle: 
Primary particle size is a physicochemical property that contributes to the degree of adsorption and is an important parameter related to in vivo applications of nanotechnology, particularly renal clearance. Nanoparticles that removed the highest amount of homocysteine after the correction for primary particle size (nano-anatase removed 2.93 mg/mg post-correction) may be best suited for = μ Adsorption corrected for primary particle size Amount Re moved ( g / mg) Pr imary particle size (nm) these theoretical applications. Correcting the results based on primary particle size helps to evaluate the effect that SSA and crystalline phase have on adsorption. In general, as SSA and anatase content increase, adsorption also increases (see the "Discussion" section). As primary particle size decreases, SSA increases because more of the surface is exposed to the surroundings relative to the amount of atoms, which are not exposed to the surface. Smaller primary particle sizes also produced the highest values of adsorbed homocysteine. Not correcting for primary particle size fails to consider the effects of primary particle size, and SSA, as each nanoparticle is unique. The idea of normalization is consistent with the work of Hsieh et al. (2013) in terms of evaluating nanoparticles with multiple different physicochemical properties in an attempt to categorize them on one particular level. All values were significant (p < 0.05) compared with the negative control, micro-sized rutile, except for P25 (p = 0.053), amorphous (p = 0.113) and NKT90 (p = 0.198).
Comparison with Extracellular Oxidative Damage
The homocysteine adsorption results correlate well with the ferric reducing ability of serum (FRAS) assay ( Figure 6 ). The FRAS assay detects decreases in serum antioxidant capacity when exposed to oxidatively damaging nanomaterials (Bello et al. 2009; Hsieh et al. 2013) . However, as mentioned by Bello and co-workers, other than biological oxidative damage (BOD), adsorption/removal from the testing matrix by a nanoparticle is another mechanism to cause a positive FRAS result. The observed results of the FRAS assay are consistent with the adsorptive properties of the TiO 2 nanoparticles observed in the present study.
DISCUSSION
In this study, the aminothiol adsorption characteristics of eight different TiO 2 nanoparticles were determined using a state-of-the-art HPLC system with fluorescence detection. This method provided an approach to quantify the property of the selected TiO 2 nanoparticles to remove homocysteine from solution under physiological-like conditions. The present study incorporated SBD-F, which specifically reacts with homocysteine in the reduced (R-SH) state. This derivatization agent dramatically increases specificity because only thiols can produce a signal. Similarly, Zhang et al. (2014a) recently used fluorescent detection with TiO 2 nanoparticles and Wu et al. (2014) developed a sensitive and specific fluorescent method to detect aminothiols using graphene quantum dots. Combining sensitive and specific fluorescence detection with nanotechnology could improve clinical aminothiol detection. Furthermore, the detection of a decrease in the homocysteine peak assured an actual decrease in homocysteine level due to increased removal by the nanoparticle. This screening system could be widely used in the field of nano-bio interactions as there are many other nanoparticles and nanomaterials capable of adsorbing/removing biomolecules. As stated in the "Experimental Analysis" section, 5-mmol homocysteine (R-SH) standard was mixed with the nanoparticles in physiological PBS for 1 hour at 37 ˚C. After exposure, the TiO 2 nanoparticles were removed by centrifugation and two further ultracentrifugation steps and a 100-ml aliquot of the sample was reduced with TCEP (Araki and Sako 1987) . The TCEP reagent is known to convert an oxidized homocysteine (homocysteine; R-S-S-R) that was formed in the procedure back to the reduced R-SH form before the HPLC measurement step. Lack of homocysteine removal would have produced results equal to that of the standard. A decreased homocysteine peak on the HPLC chromatogram reflected the degree of removal of homocysteine by adsorption onto the surface of the TiO 2 particles in solution. These results do not provide information about whether homocysteine underwent oxidation to the disulphide form either in solution or on the surface of the particles or which form was preferentially adsorbed to the surface of the particle but indicated only the fraction of total forms of homocysteine that remained in solution after particle exposure. Photocatalytic degradation of homocysteine was not evaluated. However, whether homocysteine was adsorbed or degraded, the TiO 2 nanoparticles were responsible for causing a decreased signal from the detector, which indicated a change in homocysteine concentration from the 5-mmol standard.
The observed results of this study indicate that each TiO 2 nanoparticle is capable of removing homocysteine to different extents. The differences in results within the TiO 2 species can be attributed to variations in surface characteristics and primary particle size among the various nanoparticles. The three major phase characteristics of TiO 2 are anatase, rutile and brookite. Recent studies have discovered that these nanoparticles of TiO 2 , originally thought to be biologically inert, are capable of having biologically adverse consequences . Recent research suggests that due to their small size, TiO 2 nanoparticles can penetrate basic biological structures such as cell membranes, thereby disrupting normal cellular functions and/or destroying the entire cell . The adsorption of metal ions could also occur through electrostatic interactions due to the nanoparticle's large surface area (Liu et al. 2005) .
Furthermore, Pena et al. (2005) found that arsenic could be removed from solution by adsorption using TiO 2 nanoparticles, but only between 21 and 25 ˚C and at pH < 8. The present study only observed homocysteine removal under physiological conditions (isotonic PBS, pH 7.4). As shown by Jegadeesan et al. (2010) adsorption site density is another factor that affects adsorption capacity in addition to surface area and particle crystalline structure. A study performed by Xu et al. (2010) demonstrated that lysozyme was adsorbed on the surface of TiO 2 nanoparticles by hydrogen bonds and electrostatic attractions. This removal of a biomolecule is consistent with our findings and supports that a certain degree of adverse nano-bio interactions is an inherent characteristic of different TiO 2 nanoparticles (Bello et al. 2009 ). The present study shows a significant (p £ 0.025) positive correlation (R 2 = 0.732) between FRAS BOD and homocysteine adsorption ( Figure 6 ). The FRAS assay effectively measures a decrease in serum antioxidant capacity when exposed to oxidatively damaging or adsorptive nanomaterials. According to the FRAS results, most TiO 2 nanoparticles did not significantly decrease serum antioxidant capacity except for the nano-sized anatase nanoparticle ). Moreover, primary particle size has an effect on toxicity of cells in culture. Sanders et al. (2012) found that mixtures of 25-nm-sized anatase and 31-nm-sized rutile caused a greater degree of phototoxicity to retinal epithelial cells than did 142-and 214-nm particles of anatase and rutile, respectively. With regard to the protein adsorption ability of nano-metal oxides, Joshi et al. (2012) found that the adsorption of proteins on the surface of nanoparticles depends on two factors: (i) the type and charge status of the polypeptide side chains and (ii) the type of nano-metal oxide used. In addition, differences in adsorption between nano-metal oxide types are due to differences in charge transfer and band gap bending due to formation of a space charge layer. Coordinative bond formation between metal and protein (by nitrogen atoms) is another possibility of how adsorption takes place (Joshi et al. 2012) . In addition, Song et al. (2012) found that nano-metal oxides are capable of adsorbing bovine serum albumin (BSA) to their surface, which is influenced by three major factors, namely, (i) surface area of the nanoparticles, (ii) hydrophilicity on particle surfaces, which allows for hydrogen bonding and (iii) electrostatic attraction that could affect the adsorption affinity of BSA. These published findings along with our data suggest that protein/amino acid adsorption to the surface of nanoparticles is plausible, but is influenced by multiple factors. Therefore, these data provide insight about TiO 2 nanoparticles' possible effectiveness as nanopharmaceuticals. If designed properly (surface functionalization) with a primary particle size that can clear the renal system, TiO 2 nanoparticles may be effective at targeting and removing specific biomolecules, which may be harmful to the body. However, care must be taken to ensure removal of the correct biomolecule as, according to recent literature, nanoparticles in general have been shown to remove biomolecules non-specifically (Bello et al. 2009 ).
Primary particle size, SSA, polarity and crystalline surface arrangement are primarily responsible for each nanoparticle's physicochemical properties and these differences in physicochemical properties between nanoparticles are responsible for different adsorptive abilities. Each nanoparticle in this study was composed of a different crystalline phase, SSA, primary particle size and polarity. Studies that relate a single, specific physicochemical characteristic to an effect may be ignoring the multifactorial nature of these materials. Sayes et al. (2006) report that the crystalline phase in TiO 2 nanoparticles is central for chemical reactivity and found that the different crystalline forms generated different amounts of reactive oxygen species (ROS). The results showed that both P90 and anatase nanoparticles remove nearly the same amount of homocysteine. The P90 form contains a mixture of 90% anatase and 10% rutile (Yang et al. 2013) . However, each nanoparticle was of different SSA and primary particle size. Furthermore, P25 is a mixture of 70% anatase and 30% rutile (Long et al. 2006) . The data showed that P25 comparably did not remove a large amount of homocysteine as anatase and P90 did. A reason for this could be due to the individual differences in size and SSA. The SSA of the P25 used was about half of that of P90, and is 5.5 times lower than anatase. The particle sizes also differ. The anatase nanoparticle is half the size of the P25 nanoparticle. The P90 nanoparticle is 1.5 times smaller than P25. Differences in ROS production relative to SSA and primary particle size have been observed by Jin et al. (2011) and Braydich-Stolle et al. (2009) . In addition, the rutile nanoparticle generally has a relatively larger grain size, and thus a lower SSA, which results in a decreased capacity to adsorb species including homocysteine (Hanaor and Sorrell 2011). The results were consistent with this observation. Thus, recent literature has observed differences in TiO 2 reactivity with biomolecules due to differences in crystalline structure, polarity, SSA and primary particle size.
The rutile crystalline arrangement has two atoms per unit cell, whereas anatase contains four, and both phases are arranged in a tetragonal fashion (Hanaor and Sorrell 2011). The band gaps for anatase and rutile are 3.26 and 3.06 eV, respectively, classifying both crystalline forms as semiconductors (Gurr et al. 2005) . The Ti-O bond length is very similar in both crystalline phases (Hirakawa et al. 2004) . It has been reported that the anatase arrangement is more cytotoxic/biologically active and that the rutile arrangement generates ROS (Hirakawa et al. 2004; Braydich-Stolle et al. 2009 ). The anatase structure is generally more reactive than rutile in biological matrices because water molecules dissociatively adsorb to the anatase surface as H + and HO -, whereas the rutile surface non-dissociatively adsorbs water as H 2 O (Sayes et al. 2006 ). Sayes and co-workers also report that ROS production is even greater if the TiO 2 /biological matrix interaction takes place in the presence of UV light. When exposed to UV light, reactive photocarriers are adsorbed on the surface in order to encounter TiOH species, which can form biologically detrimental hydroxyl radicals (HO •   ) . The ability of a nano-sized particle to adsorb a molecule on its surface has many potential applications. It is crucial to understand the adsorptive qualities of nanomaterials, because there are many possible uses for nanotechnology in medicine, including DNA and immunosensing nanoprobes, controlled drug delivery, faster medical diagnostics, and simple/quick biosensing (Lim et al. 2007) . Huang and Chang (2006) used the adsorptive characteristics of nano-sized gold to create a new matrix for surface-assisted laser desorption ionization mass spectrometry in the analysis of aminothiols. Nanopharmaceutical applications may allow for the removal of molecules of interest. Controlled removal of selected targets by nanoparticle adsorption is possible and represents therapeutic applications of nanotechnology. Selected removal of targeted components may be crucial for environmental applications as well.
CONCLUSIONS
The present study provides a unique avenue to study nano-bio interactions using the common nanoparticle TiO 2 . The evaluations performed by this approach provide the necessary data required for manufacturers interested in the adsorptive ability of TiO 2 nanoparticles.
Because of the multiple physicochemical properties of nano-sized metal oxides, the possibility to remove harmful biomolecules, and thus effectively extract them from their matrix, is possible whether it is a biological, environmental or another kind of matrix. TiO 2 nanoparticles offer this ability at a relatively low cost. As the demand for better quality and more cost-effective methods for treatments increase, it is certain that nanotechnology will play a role in improving health care and the environment. Use of TiO 2 nanoparticles in the proper capacity could contribute to improving current approaches.
